Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Apple
AAPL
|
+$953M |
| 2 |
NVIDIA
NVDA
|
+$784M |
| 3 |
Meta Platforms (Facebook)
META
|
+$753M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$316M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$315M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.17B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$506M |
| 4 |
Abbott
ABT
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$325M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Healthcare | 16.94% |
| 3 | Consumer Discretionary | 12.83% |
| 4 | Consumer Staples | 9.16% |
| 5 | Industrials | 9.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
TAT Technologies
TATT
$500M
| $1.26M | ﹤0.01% |
168,430
-2,372
| -1% | -$17.7K |
|
|
CLCO
2327
Cool Company
CLCO
$407M
| $1.25M | ﹤0.01% |
+91,894
| New | +$1.25M |
|
2328
Sutro Biopharma
STRO
$75.6M
| $1.25M | ﹤0.01% |
269,497
+140,100
| +108% | +$651K |
|
2329
Allogene Therapeutics
ALLO
$262M
| $1.25M | ﹤0.01% |
251,900
-176,800
| -41% | -$879K |
|
2330
Northrim BanCorp
NRIM
$488M
| $1.25M | ﹤0.01% |
31,800
-1,700
| -5% | -$66.9K |
|
2331
Transportadora de Gas del Sur
TGS
$3.35B
| $1.25M | ﹤0.01% |
+90,361
| New | +$1.25M |
|
2332
Veritex Holdings
VBTX
$1.84B
| $1.24M | ﹤0.01% |
+69,225
| New | +$1.24M |
|
2333
STRATTEC Security
STRT
$285M
| $1.24M | ﹤0.01% |
68,206
+100
| +0.1% | +$1.81K |
|
2334
SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$11.4B
| $1.24M | ﹤0.01% |
+22,700
| New | +$1.24M |
|
2335
AC Immune
ACIU
$256M
| $1.24M | ﹤0.01% |
417,979
+6,900
| +2% | +$20.4K |
|
2336
Century Casinos
CNTY
$82M
| $1.23M | ﹤0.01% |
173,849
+11,500
| +7% | +$81.6K |
|
2337
Halozyme
HALO
$8.87B
| $1.23M | ﹤0.01% |
34,080
-61,061
| -64% | -$2.2M |
|
2338
Heron Therapeutics
HRTX
$227M
| $1.23M | ﹤0.01% |
1,059,100
-81,736
| -7% | -$94.8K |
|
|
TVRD
2339
Tvardi Therapeutics, Inc. Common Stock
TVRD
$317M
| $1.23M | ﹤0.01% |
12,057
+11,069
| +1,120% | +$1.13M |
|
|
LITB
2340
LightInTheBox
LITB
$39.1M
| $1.23M | ﹤0.01% |
173,355
+2,058
| +1% | +$14.6K |
|
|
HIBB
2341
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.23M | ﹤0.01% |
33,788
-29,000
| -46% | -$1.05M |
|
2342
Taylor Devices
TAYD
$148M
| $1.22M | ﹤0.01% |
47,662
+2,100
| +5% | +$53.7K |
|
2343
BJ's Restaurants
BJRI
$668M
| $1.22M | ﹤0.01% |
38,229
-92,800
| -71% | -$2.95M |
|
2344
CBIZ
CBZ
$2.99B
| $1.22M | ﹤0.01% |
22,826
+12,826
| +128% | +$683K |
|
2345
Coastal Financial
CCB
$1.63B
| $1.21M | ﹤0.01% |
32,207
-2,567
| -7% | -$96.7K |
|
2346
iShares Core S&P Total US Stock Market ETF
ITOT
$76.8B
| $1.21M | ﹤0.01% |
12,400
+9,500
| +328% | +$929K |
|
2347
Pulmonx
LUNG
$64.4M
| $1.21M | ﹤0.01% |
92,400
-102,445
| -53% | -$1.34M |
|
2348
Pampa Energía
PAM
$3.36B
| $1.21M | ﹤0.01% |
27,953
-29,507
| -51% | -$1.28M |
|
2349
abrdn Physical Silver Shares ETF
SIVR
$2.66B
| $1.21M | ﹤0.01% |
55,300
-34,500
| -38% | -$754K |
|
2350
Standard BioTools
LAB
$527M
| $1.21M | ﹤0.01% |
625,309
+289,009
| +86% | +$558K |
|